So when they license out a portion of the biotech assets for 20 - 30 Million up front and a recurring annual fee, effectively quadrupling the market value of the company overnight, you are okay with having missed the boat?
Magic
Opportunities always look bigger going than coming!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.